What JOGO Health does

JOGO Health is a digital therapeutics company that develops the FDA-cleared JOGO-Gx, a prescription surface electromyography (sEMG) biofeedback device designed to treat chronic pain and neuromuscular disorders. The platform addresses migraine, chronic lower back pain, tension headache, TMJ pain, spasticity, cancer pain, pelvic floor dysfunction, and orthopedic prehab/rehab indications. The company's regulatory posture includes FDA 510(k) Exempt status for JOGO-Gx and FDA Breakthrough Device Designation for chronic lower back pain, positioning JOGO as a non-pharmacologic alternative in a market affecting approximately one in five people globally.

The core technology combines proprietary sEMG sensors with AI-driven signal processing to translate neuromuscular activity into cloud-based digital biomarkers for pain, fatigue, and neurological disorders, with intended integration into the FDA's Prescription Drug Use-Related Software (PDURS) pathway for combined drug-digital therapy. JOGO-Gx is engineered for both in-clinic and telehealth deployment, with clinical evidence including a Nature publication (2019), the BEAT-pain study in Digital Health Journal (2023), and a pilot RCT for episodic migraines. The Medical Advisory Board draws from Harvard Medical School, Yale, and Brigham and Women's Hospital, and certification programs (JCBP at $1,950 for licensed clinicians; JCBT at $750 for support staff) are trained by Harvard faculty.

JOGO Health operates a hybrid go-to-market: direct enterprise sales of JOGO-Gx devices and therapy subscriptions to healthcare providers, hospitals, and clinics; telehealth distribution via partners such as SohoMD; and a credentialed practitioner network built through certification programs. The company is incorporated in Delaware and headquartered in Bridgewater, New Jersey, with a wholly-owned subsidiary (JOGO Health Pvt. Ltd) operating in India. Backed by Hourglass Ventures, Mayo Clinic Ventures, and the NJ Innovation Evergreen Fund, and with IQVIA's Chairman/CEO Ari Bousbib on the board, JOGO has raised over $24 million across six disclosed funding rounds from 2019 through 2025 and remains private.

Name

JOGO Health

Legal name

JOGO Health, Inc.

Website

https://jogohealth.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

JOGO Health is a digital therapeutics company that sells the FDA-cleared JOGO-Gx sEMG biofeedback device and subscription therapy services to healthcare providers for treating chronic pain, migraine, and neuromuscular disorders, complemented by clinician certification programs.

Ownership category

akta.pro rank

Product category

Digital Therapeutics

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Home Health Care Services (62161), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Services-Home Health Care Services (8082)

akta.pro primary industry

Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN) (HLALADAD)

akta.pro secondary industries

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC)

Keywords

• Digital therapeutics
• Biofeedback therapy
• Neuromuscular disorders
• Chronic pain management
• SEMG technology

Headquarters

HQ city

Old Bridge

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Others

Revenue model

1. Certification Programs: JOGO offers two certification programs for healthcare professionals: JOGO Certified Biofeedback Professional (JCBP) at $1950 and JOGO Certified Biofeedback Technician (JCBT) at $750. These programs provide advanced clinical training and credentialing for using JOGO's FDA-cleared digital EMG technology.
2. JOGO-Gx Device Sales: Sale of the FDA-cleared JOGO-Gx EMG biofeedback device to healthcare providers and practices for in-clinic and telehealth-based biofeedback therapy programs. Pricing requires direct inquiry.
3. sEMG Biofeedback Therapy Services: JOGO Health provides sEMG biofeedback therapy services that include delivery of a JOGO-Gx device along with guided biofeedback therapy utilizing JOGO technology, incorporated into patient care plans.
4. Digital Therapeutics Platform Licensing: AI-powered, FDA-cleared wearable technology platform providing non-invasive relief for neuromuscular disorders and chronic pain. Funds support commercial launch and growth efforts.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

JOGO Health develops and sells the FDA 510(k) Exempt JOGO-Gx surface electromyography (sEMG) biofeedback device, an AI-powered prescription digital therapeutic for treating neuromuscular disorders and chronic pain conditions including migraine, chronic lower back pain, pelvic floor dysfunction, TMJ pain, and spasticity. The company also delivers guided sEMG biofeedback therapy services for in-clinic and telehealth use, and runs paid clinician certification programs (JCBP and JCBT) that credential healthcare professionals to deliver JOGO therapy.

Product overview

JOGO Health is a comprehensive digital neurology platform that bridges digital therapeutics and traditional pharmacology. The core product is the JOGO-Gx, an FDA 510(k) Exempt sEMG biofeedback device that provides real-time visual and auditory feedback for treating neuromuscular disorders and chronic pain conditions. The company complements its hardware with two certification programs (JCBP and JCBT) that train healthcare professionals to deliver evidence-based biofeedback therapy. The platform leverages AI to translate neuromuscular signals into objective digital biomarkers, integrating data-driven insights with targeted drug therapies under FDA's PDURS pathway.

Differentiator

Problem solved

Functional benefit

Brands

• JOGO-Gx: FDA 510(k) Exempt EMG Biofeedback Device - prescription biofeedback device designed for use in both clinical and telehealth settings using surface electromyography technology.

Products and services

• JOGO-Gx sEMG Biofeedback Device The JOGO-Gx is an FDA 510(k) Exempt prescription biofeedback device that uses surface electromyography (sEMG) to measure muscle activity and provide real-time visual and auditory feedback during biofeedback therapy sessions. It is sold to healthcare providers and practices for in-clinic and telehealth-based biofeedback therapy programs targeting neuromuscular disorders and chronic pain conditions including migraine, chronic lower back pain, TMJ pain, tension headache, pelvic floor disorders, spasticity, and cancer pain.
• JOGO Certified Biofeedback Professional (JCBP) The JCBP is a paid advanced certification program that trains licensed clinicians such as Physician Assistants, Clinical Psychologists, Nurse Practitioners, Physical Therapists, and Occupational Therapists to deliver evidence-based biofeedback using JOGO's FDA-cleared digital EMG technology. The program covers EMG biofeedback, JOGO protocols, remote care delivery, and tele-biofeedback workflows, and awards a credential upon completion.
• JOGO Certified Biofeedback Technician (JCBT) The JCBT is a paid certification program that trains clinical support staff such as Medical Assistants and Physical Therapy Assistants to assist with biofeedback sessions under licensed supervision. It covers the basics of biofeedback, sensor placement, patient setup, and workflow integration.
• JOGO sEMG Biofeedback Therapy Services JOGO Health's sEMG biofeedback therapy services include delivery of a JOGO-Gx device along with guided biofeedback therapy using JOGO technology, incorporated into patient care plans. Services are delivered in clinical settings and via telehealth, with pricing on an annual subscription basis requiring direct inquiry.

Quantifiable outcome

• Published clinical evidence in Nature (2019) demonstrating effect of surface electromyography biofeedback on extensor and dorsiflexor muscles in elderly adults
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• SohoMDcoreStrategic or Co-development Partner · 13 October 2025Partnership with SohoMD, a virtual mental health provider, to improve migraine management through an integrated neurological and mental health care approach. Collaboration leverages combined resources to expand access to FDA-cleared digital migraine solution and address comorbid nature of migraine and mental health issues.
• Harvard Medical SchoolcoreStrategic or Co-development PartnerHarvard Medical School faculty train JOGO's certification programs. Faculty members including Dr. Inna Khazan, Dr. Asimina Lazaridou, Dr. Carolyn A Bernstein, and Dr. Robert R Edwards serve on JOGO's Medical Advisory Board and certification faculty.
• Brigham and Women's HospitalcoreStrategic or Co-development PartnerMultiple faculty members from Brigham and Women's Hospital (Harvard Medical School affiliate) serve on JOGO's Medical Advisory Board and contribute to clinical research and certification training.
• Parkinson's FoundationminorStrategic or Co-development PartnerPartner organization shown in JOGO Health's partner logos section, indicating collaboration or mutual support in Parkinson's disease research and treatment.
• Johnson & Johnson JLABSminorStrategic or Co-development PartnerJohnson & Johnson JLABS (Janssen Labs) shown as partner logo, indicating connection to Johnson & Johnson's healthcare innovation ecosystem.
• Digital Therapeutics AllianceminorStrategic or Co-development PartnerDigital Therapeutics Alliance (DTA) partnership indicates JOGO Health's participation in the industry association for digital therapeutics companies.
• Long COVID AllianceminorStrategic or Co-development PartnerLong COVID Alliance partnership indicates collaboration in addressing long COVID symptoms including neurological and neuromuscular conditions.
• IQVIAcoreStrategic or Co-development PartnerBoard member Ari Bousbib serves as Chairman and CEO of IQVIA, the world's leading clinical research organization with over 58,000 employees and $11 billion in revenue. JOGO Health's previous venture (Semantelli) was acquired by IQVIA where Siva Nadarajah served as General Manager for six years.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Hinge Health: Hinge Health is a leading digital musculoskeletal care platform offering exercise therapy, wearable sensors, and coaching for back, joint, and chronic pain. It overlaps directly with JOGO on chronic lower back pain and MSK use cases delivered through digital and sensor-based programs.
• Sword Health: Sword Health is a digital MSK and pelvic health platform combining AI-powered exercise therapy with clinician oversight. It competes with JOGO across chronic pain and pelvic floor indications and shares a digital-first, employer- and payer-channel GTM.
• Kaia Health: Kaia Health delivers app-based digital therapy for MSK pain and COPD using self-management and AI coaching. It is comparable to JOGO as a software-led digital therapeutic targeting chronic pain with similar enterprise and payer distribution.
• NeuroMetrix: NeuroMetrix is a wearable neurostimulation company (Quell device) focused on chronic pain management using electrical and sensor-based technology. It is highly comparable to JOGO as a prescription-grade wearable bioelectronic/EMG-based platform for chronic pain.
• Click Therapeutics: Click Therapeutics develops prescription digital therapeutics across migraine, schizophrenia, and cardiometabolic conditions. It is comparable to JOGO as a fellow prescription-grade digital therapeutics company pursuing FDA-cleared software plus combination-therapy strategies.
• Akili Interactive: Akili Interactive pioneered FDA-cleared prescription digital therapeutics (initially for ADHD) and has expanded into broader cognitive and neurological conditions. It is comparable as a category peer in prescription digital neurology and serves as a benchmark for JOGO's commercialization pathway.
• HeartMath: HeartMath is a long-standing biofeedback and heart-rate-variability training company serving both consumers and clinicians. It is comparable to JOGO in the underlying biofeedback modality category, with overlapping chronic stress and pain management use cases.

Broad incumbents

• Omada Health: Omada Health is a large-scale virtual care platform for chronic conditions (diabetes, hypertension, MSK). It is comparable as an established chronic-condition digital therapeutics incumbent with employer/payer channels that JOGO could overlap with in enterprise sales.

Emerging players

• Mahana Therapeutics: Mahana Therapeutics is a digital therapeutics company focused on gastrointestinal conditions (e.g., IBS) using prescription CBT-based software. It is comparable to JOGO as a fellow prescription digital therapeutics player addressing gut-brain and chronic conditions in adjacent clinical areas.
• Lin Health: Lin Health is an emerging digital chronic-pain platform combining behavioral therapy, coaching, and sensor data. It overlaps with JOGO on chronic pain and employer-channel distribution, and represents a next-generation competitor pursuing hybrid digital-plus-sensor pain care.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/healthjogo
• Facebookfacebook.com/jogohealth
• LinkedInlinkedin.com/company/jogo-health

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries1 record

Funding overview

Funding rounds6 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JOGO Health